The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer. (2018)

First Author: Evans JP

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.25497

PubMed Identifier: 29930754

Publication URI: http://europepmc.org/abstract/MED/29930754

Type: Journal Article/Review

Volume: 9

Parent Publication: Oncotarget

Issue: 43

ISSN: 1949-2553